BF
MYGN icon

BOK Financial’s Myriad Genetics MYGN Stock Holding History

BOK Financial’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-159
Closed -$3.04K – 1283
2023
Q4 		$3.04K Buy
+159
New +$2.75K ﹤0.01% 1068
2023
Q3 		– Sell
-144
Closed -$3.34K – 1247
2023
Q2 		$3.34K Hold
144
– – ﹤0.01% 1002
2023
Q1 		$3.35K Buy
+144
New +$2.92K ﹤0.01% 1086
2015
Q3 		– Sell
-56,952
Closed -$1.94M – 867
2015
Q2 		$1.94M Buy
56,952
+2,249
+4% +$76.5K 0.07% 324
2015
Q1 		$1.94M Buy
54,703
+10,155
+23% +$363K 0.07% 324
2014
Q4 		$1.52M Sell
44,548
-15,789
-26% -$560K 0.05% 338
2014
Q3 		$2.33M Sell
60,337
-29,631
-33% -$1.11M 0.08% 278
2014
Q2 		$3.5M Buy
89,968
+8,991
+11% +$335K 0.11% 201
2014
Q1 		$2.77M Buy
80,977
+8,405
+12% +$260K 0.09% 238
2013
Q4 		$1.52M Buy
72,572
+21,096
+41% +$534K 0.05% 347
2013
Q3 		$1.21M Buy
51,476
+37,789
+276% +$1.07M 0.04% 381
2013
Q2 		$368K Buy
+13,687
New +$397K 0.01% 616

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BOK Financial's MYGN Position: Q1 2024 in Review

BOK Financial sold out of Myriad Genetics (MYGN) in Q1 2024, closing a stake of 159 shares — an estimated $3.04K sold.

BOK Financial first reported a position in MYGN in Q2 2013 and held it in 12 quarters. The position peaked at $3.5M in Q2 2014. 186 funds tracked by Wall St. Rank hold MYGN as of Q1 2024.

  • BOK Financial reported no remaining Myriad Genetics position as of Q1 2024 after selling out during the quarter.
  • BOK Financial sold 159 Myriad Genetics shares in Q1 2024, an estimated $3.04K.
  • BOK Financial first reported a position in Myriad Genetics in Q2 2013 and held it in 12 quarters.
  • BOK Financial's Myriad Genetics position peaked at $3.5M in Q2 2014.
  • 186 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2024.

Based on BOK Financial's 13F filing for Q1 2024, filed 15 May 2024.